0.4 ML nogapendekin alfa inbakicept-pmln 1 MG/ML Intravesical Solution [Anktiva]
RxNorm concept 2682691, branded drug (sbd). Prescribable name: Anktiva 400 MCG in 0.4 ML Intravesical Solution.
- RxCUI
- 2682691
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2682691 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
0.4 ML Anktiva 1 MG/ML Intravesical Solution; Anktiva 400 MCG per 0.4 ML Intravesical Solution
Related concepts
- nogapendekin alfa inbakicept-pmln 1 MG/ML (SCDC, consists of)
- nogapendekin alfa inbakicept-pmln 1 MG/ML [Anktiva] (SBDC, consists of)
- Intravesical Solution (DF, has dose form)
- Anktiva (BN, has ingredient)
- 0.4 ML nogapendekin alfa inbakicept-pmln 1 MG/ML Intravesical Solution (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2682691 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2682691 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2682691. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.